1. Saraiya Usha B
2. Kulkarni Yogesh

9789351521839

10.5005/jp/books/12444_48

1/e

2015

8

1. Cama and Albless Hospital, Mumbai, Sir HN Hospital, Saifee Hospital and Breach Candy Hospital, Mumbai, India, Cama and Albless Hospital, Mumbai, India; CT Hsu Orator 2002 in Bangalore, FIGO 2003, India for Journal of Obstetrics and Gynaecology and Research (AOFOG Journal), Bangladesh Institute of Cancer Research, Indian College of Obstetricians and Gynaecologists, Sir HN Hospital, Saifee Hospital, and Breach Candy Hospital; Cama and Albless Hospital, Mumbai, India; CT Hsu Orator 2002 in Bangalore; FIGO 2003, India for Journal of Obstetrics and Gynaecology and Research (AOFOG Journal); Bangladesh Institute of Cancer Research; Indian College of Obstetricians and Gynaecologists, Sir HN Hospital, Saifee Hospital and Breach Candy Hospital, Mumbai, India; Cama and Albless Hospital, Mumbai, India; CT Hsu Orator 2002 in Bangalore; FIGO 2003, Journal of Obstetrics and Gynaecology and Research (AOFOG Journal); Bangladesh Institute of Cancer Research; Indian College of Obstetricians and Gynaecologists, Sir HN Hospital,
2. Nowrosjee Wadia Maternity, Parel, Mumbai, India, N Wadia Maternity Hospital, Mumbai, India, Kokilaben Dhirubhai Ambani Hospital and Research Center, Mumbai, Maharashtra, India

Ovulation inducing agents, Medroxyprogesterone acetate, ER/PR expression, Tamoxifen, grade I endometrioid cancers